In the Past 30 Days...
PER WEEK
PER POST
PER POST
In the last 30 days, the average company in this landscape has grown their audience by <0.1%. Gilead Sciences grew faster than everyone else, with 0.4% growth! On average, each post in this landscape earns more than 124.4 engagements. Abbott is topping the charts with more than 750.0 engagements per post on their 22 posts in the last 30 days.
273 Likes • 3 Comments
Just a few years ago, paralysis or speech loss were a common consequence of strokes. While the treatment of this acute condition remains extremely challenging, there are rays of hope. Marios Psychogios, Head of Neuroradiology at University Hospital Basel and professor, makes a significant contribution to improving the quality of life of stroke patients with …
250 Likes • 1 Comments
PRIDE is a moment to recognise the importance of workplaces where everyone feels respected and empowered to contribute fully. By celebrating PRIDE and our LGBTQIA+ community, we strengthen an environment where: 🔹 Different perspectives are valued 🔹 People can show up authentically at work 🔹 We continuously strengthen our culture of care When our people thrive in this inclusive …
205 Likes • 0 Comments
The energy at #ASCO26 underscored just how quickly oncology is evolving and how much more is possible for people living with cancer. Together with Kite Pharma, we're helping translate that energy into real progress by advancing scientific innovation in ways that can make a meaningful difference for patients and those who care for them. Because expanding …
105 Likes • 3 Comments
In the 2026 #FIFAWorldCup, every moment matters for the players—just like it does for our patients. Hear from CEO Chris Boerner and #BMSWontLose patient and caregiver voices about what this moment means to them—and how they inspire us to deliver real breakthroughs to more people. #OneBMS
83 Likes • 5 Comments
May brought the energy. We brought the impact. 🍎 Delivered food access through Aetna’s School Nutrition Program in Florida to Title I schools in partnership with mobileschoolpantry 🏆 Artey, our AI digital assistant, earned Gold for employee experience innovation ⚽ Celebrated community pride through our ussoccer fleet designs 🍽️ Aetna colleagues supported families at ronaldmcdonaldhouse of Dallas 🎤 Connected across …
1.29k Reactions • 27 Comments • 130 Shares
Hydration station 🤝 Slimey’s pool vacation #AbbottHealthyHabits
716 Reactions • 41 Comments • 41 Shares
#Sponsored #BMSAmbassador Multiple myeloma hits close to home for my family. When my father was diagnosed over 20 years ago, hope was our anchor. That's why I'm proud to team up with Bristol Myers Squibb to revisit my dad’s story and raise awareness of CELMoD research, a new area of scientific investigation that’s giving myeloma patients …
32 Reactions • 13 Comments • 2 Shares
Ready for life’s bumps, scrapes and surprises? Here’s some advice on packing a first aid kit. #FirstAidKit #FirstAid #EmergencyPreparation #FirstAidTraining
20 Reactions • 17 Comments • 1 Shares
Check out this week's Extra Big Deals! Use your ExtraCare card to get these deals June 7 to June 20, online and in store.
30 Reactions • 0 Comments • 4 Shares
"Victory must belong to patients.” Hear from CEO Chris Boerner why #BMSWontLose when it comes to delivering the next breakthrough for patients and caregivers who are waiting: https://bit.ly/3RPRVSh #OneBMS
22 Likes • 6 Retweets
Pfizer is advancing obesity science. New Phase 2b data for our investigational GLP‑1 RA peptide show robust efficacy and favourable GI tolerability across weekly and monthly dosing, supporting our extensive pivotal program. Learn more: [link] #ADASciSessions #Obesity #GLP1 pic.x.com/LhG9IklU7n
16 Likes • 7 Retweets
#MEDIA: Today, we’re launching Investigating Myeloma, a #MultipleMyeloma awareness campaign in partnership with Mariska Hargitay, which spotlights the importance of ongoing scientific innovation, including a research approach called CELMoD. Read more: bit.ly/3SsuFtB pic.x.com/nl8LhwbEyJ
11 Likes • 6 Retweets
#GileadNews: Today, in collaboration with @Merck, we announced positive topline results from a Phase 3 study evaluating an investigational long-acting oral HIV treatment. Read the full press release here: gilead.inc/4xfl21p pic.x.com/VtcCOt3tZd
14 Likes • 4 Retweets
Not all migraine attacks are random. Hormonal shifts during your menstrual cycle can trigger longer attacks with more severe symptoms. Understanding the science can help you anticipate triggers and explore ways to address symptoms. on.pfizer.com/49IpbAY #MigraineRelief pic.x.com/s4XPuKY62T
9 Likes • 4 Retweets
#GileadNews: Today, we completed our acquisition of Ouro Medicines to advance T cell engager therapies for autoimmune diseases. This builds on our long-term strategy to focus on developing transformative medicines that address significant unmet need. gilead.inc/3Q5CpAZ pic.x.com/nCHVzX1XHk
The Social Media Benchmark Report
Ready to see how you stack up to your industry’s top social performers? Review the latest metrics on channels, engagement, post types, and more.